Eurofins · 1 month ago
Scientist I, Investigations
United States
Full-time
Remote
Mid Level
$23/hr - $25/hr
1+ years expEurofins Scientific is an international life sciences company providing analytical testing services to enhance safety and sustainability. They are seeking a Scientist I to join their Investigations team in the Biochemistry department, focusing on conducting and reporting studies under CGMP and GLP guidelines.
BiotechnologyLife ScienceHealthcarePharmaceuticalGeneticsHealth Care
No H1B
Responsibilities
Completing work for research and development under CGMP and/or GLP guidelines for studies, documentation, etc
Assisting in conducting, monitoring and reporting studies to ensure data accuracy and report quality
Providing somewhat complex analytical work on projects and studies using a range of analytical techniques and instruments
Working with increasing independence on studies and assignments
Qualification
Required
Have practical knowledge of laboratory instrumentation (HPLC, CE-SDS, icIEF, ELISA, cell-based assays, etc.)
Bachelor's degree in relevant field such as chemistry, biochemistry, biology, chemical engineering, pharmaceutical sciences, or other directly related field or degree with comparable coursework in the above areas
1-3 years of experience working in a cGMP compliant lab
Preferred
Experience with a LIMS system desirable
Understanding of internal processes for investigational work
Ability to assess root cause using fishbone or 5 why's
Ability to drive CAPAs and Investigations to completion on tight timelines by working across multiple departments
Attention to detail
Ability to work on multiple on-going projects
Benefits
Comprehensive medical coverage, dental, and vision options
Life and disability insurance
401(k) with company match
Paid vacation and holidays
Company
Eurofins
Eurofins provides testing and support services to the pharmaceutical, food, environmental, and consumer products industries.
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$1.05B2025-06-26Post Ipo Debt· $584.64M
2025-03-27Post Ipo Debt· $432.03M
2021-10-22Grant· $30M
Leadership Team
C
Cara Ahern
Documentation Specialist
Yves-Loic Martin
Board Member
Recent News
2026-07-20
Company data provided by crunchbase